Beta Bionics, Inc.

BBNX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0002048497-26-000002
Filing date: Mar 5, 2026
Earliest execution date: Mar 4, 2026
Reporting Owners: Hopman Mark (Chief Commercial Officer)
SEC Filing link

Summary

Type

Sell

Net shares

-353

% of shares

-0.25%

Amount (USD)

$4,084

Insider confidence score

52.5 out of 100

Positive

  • Under Rule 10b5-1 trading plan
  • Small scheduled sell (<0.5% of shares)
  • Minimal sell amount (<$10K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-03-04

Code

S

Net shares

-353.0

Price per Share

$11.57

Amount (USD)

$4,084.21

Acquired/Disposed

Disposed

Shares Owned Before

139,486.0

Shares Owned After

139,133.0

Filing's footnotes

1. Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.